Compound Detail
CHEMBL3622821
UPADACITINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3622821 |
| Name | UPADACITINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WYQFJHHDOKWSHR-MNOVXSKESA-N |
| Therapeutic | ✓ Yes |
32
Targets
157
Activities
4
Assay Types
4
PK Parameters
20
Publications
4
Known Names
13
Indications
Molecular Properties
380.4
MW (Da)
2.91
ALogP
4
HBA
2
HBD
78.3
PSA (Ų)
0.73
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2019 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Alopecia Areata Arthritis, Juvenile Arthritis, Psoriatic Arthritis, Rheumatoid Colitis, Ulcerative Crohn Disease Dermatitis, Atopic Giant Cell Arteritis Hidradenitis Suppurativa Spondylitis, Ankylosing Takayasu Arteritis Vitiligo Lupus Erythematosus, Systemic
ATC Classification
L04AF03
upadacitinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSUPPRESSANTS
Activity Summary
IC50 153 meas. best 9.1
Kd 2 meas. best 5.66
EC50 1 meas. best 7.85
Ki 1 meas. best 9.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 9.1 | 7.6118 | 0.8 | 39 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | Ki | 9.05 | 9.05 | 0.9 | 1 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 8.8 | 6.847 | 1.6 | 27 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 8.8 | 7.2806 | 1.6 | 32 |
| JAK3/JAK1 CHEMBL3038491 | IC50 | 8.7 | 8.028 | 2.0 | 5 |
| JAK2/JAK1 CHEMBL3038492 | IC50 | 8.52 | 8.12 | 3.0 | 2 |
| JAK1/TYK2 CHEMBL3301391 | IC50 | 8.4 | 7.86 | 4.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 7.85 | 7.85 | 14.0 | 1 |
| Tyrosine-protein kinase JAK1 CHEMBL2968 | IC50 | 7.85 | 7.85 | 14.0 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL3553 | IC50 | 7.52 | 5.9129 | 30.0 | 14 |
| Janus Kinase (JAK) CHEMBL2363062 | IC50 | 7.35 | 7.35 | 45.0 | 1 |
| Rho-associated protein kinase 2 CHEMBL2973 | IC50 | 6.38 | 6.38 | 420.0 | 2 |
| Tyrosine-protein kinase JAK2 CHEMBL1649049 | IC50 | 6.23 | 6.23 | 593.0 | 1 |
| Rho-associated protein kinase 1 CHEMBL3231 | IC50 | 6.04 | 6.04 | 920.0 | 2 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| Tyrosine-protein kinase JAK3 CHEMBL5250 | IC50 | 5.73 | 5.73 | 1860.0 | 1 |
| Cyclin-G-associated kinase CHEMBL4355 | Kd | 5.66 | 5.66 | 2200.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type 1D CHEMBL5073 | IC50 | 5.64 | 5.64 | 2300.0 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 5.62 | 5.62 | 2400.0 | 2 |
| Leukocyte tyrosine kinase receptor CHEMBL5627 | IC50 | 5.57 | 5.57 | 2700.0 | 2 |
| Non-receptor tyrosine-protein kinase TYK2 CHEMBL2321619 | IC50 | 5.57 | 5.57 | 2715.0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 CHEMBL4045 | IC50 | 5.35 | 5.35 | 4500.0 | 1 |
| Aurora kinase A CHEMBL4722 | IC50 | 5.35 | 5.35 | 4500.0 | 2 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 5.32 | 5.32 | 4800.0 | 2 |
| Protein kinase C theta type CHEMBL3920 | IC50 | 5.29 | 5.29 | 5100.0 | 2 |
| Activated CDC42 kinase 1 CHEMBL4599 | IC50 | 5.29 | 5.29 | 5100.0 | 2 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 5.26 | 5.26 | 5500.0 | 1 |
| Aurora kinase B CHEMBL2185 | IC50 | 5.26 | 5.26 | 5500.0 | 1 |
| G protein-coupled receptor kinase 5 CHEMBL5678 | IC50 | 5.1 | 5.1 | 7900.0 | 1 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | IC50 | 5.02 | 5.02 | 9600.0 | 1 |
| Serine/threonine-protein kinase 16 CHEMBL3938 | IC50 | 5.01 | 5.01 | 9700.0 | 2 |
| AP2-associated protein kinase 1 CHEMBL3830 | Kd | 5.0 | 5.0 | 9900.0 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 83.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 480.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 83.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 25.0 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine